Weiwei An
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Molecular Biology top 10%
- Enzyme function and inhibition 5
- Phenothiazines and Benzothiazines Synthesis and Activities 5
- RNA Research and Splicing 4
- bioluminescence and chemiluminescence research 3
- Biochemistry top 10%
- Spectroscopy top 10%
-
- Cell Adhesion Molecules Research 4
-
- Synthesis and Catalytic Reactions 3
- Co-authors
- Alexander R. LippertAudrey G. ReevesQingzhong XiaoJian CaoQishan ChenEithne Margaret MaguireMei YangLi Zhang
- Journals
- Cardiovascular Research (4 papers)PLoS Genetics (2 papers)Journal of the American Heart Association (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Weiwei An
31 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 250
- Molecular Biology 694
- Biochemistry 67
- Immunology 150
- Spectroscopy 116
Countries citing papers authored by Weiwei An
This map shows the geographic impact of Weiwei An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei An more than expected).
Fields of papers citing papers by Weiwei An
This network shows the impact of papers produced by Weiwei An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei An. The network helps show where Weiwei An may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weiwei An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2022 | 31 | |
| 4 | 2022 | 11 | |
| 5 | 2021 | 62 | |
| 6 | 2021 | 31 | |
| 7 | 2021 | 16 | |
| 8 | 2020 | 16 | |
| 9 | 2019 | 23 | |
| 10 | 2019 | 28 | |
| 11 | 2018 | 30 | |
| 12 | 2018 | 100 | |
| 13 | 2018 | 25 | |
| 14 | 2018 | 23 | |
| 15 | 2017 | 43 | |
| 16 | 2017 | 37 | |
| 17 | 2016 | 49 | |
| 18 | 2015 | 15 | |
| 19 | 2015 | 41 | |
| 20 | 2010 | 7 |
About Weiwei An
Weiwei An is a scholar working on Immunology and Allergy, Cancer Research, Bioengineering, Immunology and Molecular Biology, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Enzyme function and inhibition (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers), MicroRNA in disease regulation (4 papers), Cell Adhesion Molecules Research (4 papers), Cancer-related molecular mechanisms research (4 papers), RNA Research and Splicing (4 papers), bioluminescence and chemiluminescence research (3 papers) and Synthesis and Catalytic Reactions (3 papers). The work is most often cited by research in Cancer Research (250 citations), Molecular Biology (694 citations), Biochemistry (67 citations), Immunology (150 citations) and Spectroscopy (116 citations). Weiwei An has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Alexander R. Lippert, Audrey G. Reeves, Qingzhong Xiao, Jian Cao, Qishan Chen, Eithne Margaret Maguire, Mei Yang, Li Zhang, Ralph P. Mason and Le Anh Luong. Their work appears in journals such as Cardiovascular Research, PLoS Genetics, Journal of the American Heart Association, Journal of Medicinal Chemistry and Journal of Enzyme Inhibition and Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.